Annual CFF
$479.70 M
+$360.01 M+300.78%
31 December 2023
Summary:
MoonLake Immunotherapeutics annual cash flow from financing activities is currently $479.70 million, with the most recent change of +$360.01 million (+300.78%) on 31 December 2023. MLTX annual CFF is now at all-time high.MLTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$183.10 K
+$183.10 K+100.00%
30 September 2024
Summary:
MoonLake Immunotherapeutics quarterly cash flow from financing activities is currently $183.10 thousand, with the most recent change of +$183.10 thousand (+100.00%) on 30 September 2024. Over the past year, it has increased by +$183.10 thousand (+100.00%). MLTX quarterly CFF is now -99.96% below its all-time high of $451.29 million, reached on 30 June 2023.MLTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$79.58 M
+$183.10 K+0.23%
30 September 2024
Summary:
MoonLake Immunotherapeutics TTM cash flow from financing activities is currently $79.58 million, with the most recent change of +$183.10 thousand (+0.23%) on 30 September 2024. Over the past year, it has dropped by -$371.71 million (-82.37%). MLTX TTM CFF is now -85.00% below its all-time high of $530.68 million, reached on 31 March 2024.MLTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MLTX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +300.8% | +100.0% | -82.4% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
MLTX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +300.8% | -100.0% | -85.0% | +430.4% | |
| 5 y | 5 years | at high | +300.8% | -100.0% | -85.0% | +430.4% | |
| alltime | all time | at high | +300.8% | -100.0% | -85.0% | +430.4% |
MoonLake Immunotherapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $183.10 K(>+9900.0%) | $79.58 M(+0.2%) |
| June 2024 | - | $0.00(-100.0%) | $79.39 M(-85.0%) |
| Mar 2024 | - | $50.98 M(+79.4%) | $530.68 M(+10.6%) |
| Dec 2023 | $479.70 M | $28.42 M(>+9900.0%) | $479.70 M(+6.3%) |
| Sept 2023 | - | $0.00(-100.0%) | $451.29 M(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $451.29 M(>+9900.0%) | $451.29 M(+331.1%) |
| Mar 2023 | - | $0.00(-100.0%) | $104.69 M(-12.5%) |
| Dec 2022 | $119.69 M | $3800.00(>+9900.0%) | $119.69 M(+0.0%) |
| Sept 2022 | - | $0.00(-100.0%) | $119.69 M(0.0%) |
| June 2022 | - | $104.69 M(+597.7%) | $119.69 M(+697.7%) |
| Mar 2022 | - | $15.00 M | $15.00 M |
FAQ
- What is MoonLake Immunotherapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual CFF year-on-year change?
- What is MoonLake Immunotherapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly CFF year-on-year change?
- What is MoonLake Immunotherapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM CFF year-on-year change?
What is MoonLake Immunotherapeutics annual cash flow from financing activities?
The current annual CFF of MLTX is $479.70 M
What is the all time high annual CFF for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual cash flow from financing activities is $479.70 M
What is MoonLake Immunotherapeutics annual CFF year-on-year change?
Over the past year, MLTX annual cash flow from financing activities has changed by +$360.01 M (+300.78%)
What is MoonLake Immunotherapeutics quarterly cash flow from financing activities?
The current quarterly CFF of MLTX is $183.10 K
What is the all time high quarterly CFF for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly cash flow from financing activities is $451.29 M
What is MoonLake Immunotherapeutics quarterly CFF year-on-year change?
Over the past year, MLTX quarterly cash flow from financing activities has changed by +$183.10 K (+100.00%)
What is MoonLake Immunotherapeutics TTM cash flow from financing activities?
The current TTM CFF of MLTX is $79.58 M
What is the all time high TTM CFF for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM cash flow from financing activities is $530.68 M
What is MoonLake Immunotherapeutics TTM CFF year-on-year change?
Over the past year, MLTX TTM cash flow from financing activities has changed by -$371.71 M (-82.37%)